Janux Therapeutics
(NASDAQ) JANX
Janux Therapeutics Financials at a Glance
Market Cap
$902.74M
Revenue (TTM)
$17.88M
Net Income (TTM)
$113.63M
EPS (TTM)
$-1.83
P/E Ratio
-8.09
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$14.87
Volume
35,911
Open
$14.13
Price
$14.87
Volume
35,911
Open
$14.13
Previous Close
$14.87
Daily Range
$14.13 - $14.88
52-Week Range
$12.12 - $35.34
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$14.87
Volume
35,911
Open
$14.13
Previous Close
$14.87
Daily Range
$14.13 - $14.88
52-Week Range
$12.12 - $35.34
JANX News
JANX: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Janux Therapeutics
Industry
Biotechnology
Sector
Health CareEmployees
109
CEO
David Campbell, PhD
Website
www.januxrx.comHeadquarters
San Diego, CA 92037, US
JANX Financials
Key Financial Metrics (TTM)
Gross Margin
47%
Operating Margin
-9%
Net Income Margin
-6%
Return on Equity
-11%
Return on Capital
-16%
Return on Assets
-11%
Earnings Yield
-12.36%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$902.74M
Shares Outstanding
60.83M
Volume
35.91K
Short Interest
0.00%
Avg. Volume
1.33M
Financials (TTM)
Gross Profit
$7.97M
Operating Income
$157.67M
EBITDA
$111.60M
Operating Cash Flow
$82.23M
Capital Expenditure
$1.04M
Free Cash Flow
$83.28M
Cash & ST Invst.
$966.57M
Total Debt
$22.14M
Janux Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$7.88M
N/A
Gross Profit
$1.06M
N/A
Gross Margin
-13.45%
N/A
Market Cap
$902.74M
N/A
Market Cap/Employee
$9.92M
N/A
Employees
91
N/A
Net Income
$31.95M
-58.0%
EBITDA
$31.43M
-10.2%
Quarterly Fundamentals
Net Cash
$924.68M
-7.7%
Accounts Receivable
$6.43M
+19.5%
Inventory
$0.00
N/A
Long Term Debt
$39.49M
+85.6%
Short Term Debt
$2.39M
+36.8%
Return on Assets
-11.34%
N/A
Return on Invested Capital
-16.15%
N/A
Free Cash Flow
$54.63M
+425.8%
Operating Cash Flow
$53.69M
+421.0%